Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342264 · ClinicalTrials.gov registry record
A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,187
- Enrollment target
NCT00342264: Completed study, sponsored by National Cancer Institute (NCI).
NCT00342264 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342264 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,187 participants
- Enrollment target
Study Summary
Diesel exhaust has been classified as a probable carcinogen by the International Agency for Research on Cancer and as a potential carcinogen by the National Institute for Occupational Safety and Health (NIOSH). The carcinogenicity of this pollutant is of concern not only for the one million workers who are exposed occupationally, but also for the general population. Over 30 epidemiologic studies of diesel exhaust exposure have been performed, and the results suggest an increase in lung cancer risk. However, the association is not well defined. Past studies have suffered from the use of crude indicators of exposure, inadequate control of confounding, and/or short follow-up periods, low exposure levels, and small numbers of observations. NCI and NIOSH are collaborating on two related studies of diesel exhaust under the NCI/NIOSH Interagency Agreement. First, a retrospective cohort mortality study of about 8,200 non-metal miners will be performed to investigate lung cancer mortality in relation to quantitative measures of diesel exhaust exposure, and to determine whether there is evidence of elevated mortality from other causes of death among diesel exhaust exposed miners. The retrospective cohort study will be performed using existing records and information and has been exempted from IRB review. NIOSH is the lead agency on the retrospective cohort study. The proposed study is a case-control study nested in the retrospective cohort of non-metal miners. The study is expected to include at least 160 members of the cohort who died from lung cancer and four matched controls for each case. Using a structured questionnaire, detailed information will be collected on each subject's lifetime exposure to diesel exhaust, as well as information on smoking and other confounders. This information will allow investigators to examine the association between lung cancer and different quantitative measures of diesel exhaust exposure, adjusted for smoking and other potential confounde
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,187 participants |
| Start Date | 1999-01-12 |
| Est. Completion | 2024-04-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00342264
The ClinicalTrials.gov registry entry for NCT00342264 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00342264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00342264 about?
NCT00342264 is a clinical study titled "A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners". Diesel exhaust has been classified as a probable carcinogen by the International Agency for Research on Cancer and as a potential carcinogen by the National Institute for Occupational Safety and Health (NIOSH). The carcinogenicity of this pollutant is of concern not only for the one million workers ...
What is the current status of trial NCT00342264?
This trial is currently completed. The enrollment target is 1,187 participants. The study started on 1999-01-12. Estimated completion is 2024-04-16.
Who is sponsoring clinical trial NCT00342264?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.